|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Tumor Biology |
Departments of Neurology (R.A., J.L.), Oncology (R.A., J.L.), and Neuroscience (J.L.), The Johns Hopkins University School of Medicine and The Kennedy Krieger Research Institute, Baltimore, MD 21205, USA
2 Address correspondence to John Laterra, Kennedy Krieger Research Institute, 707 N. Broadway, Baltimore, MD 21205, USA (Laterra{at}kennedykrieger.org).
Abstract
The multifunctional growth factor scatter factor/hepatocyte growth factor (SF/HGF) and its receptor tyrosine kinase c-Met have emerged as key determinants of brain tumor growth and angiogenesis. SF/HGF and c-Met are expressed in brain tumors, the expression levels frequently correlating with tumor grade, tumor blood vessel density, and poor prognosis. Overexpression of SF/HGF and/or c-Met in brain tumor cells enhances their tumorigenicity, tumor growth, and tumor-associated angiogenesis. Conversely, inhibition of SF/HGF and c-Met in experimental tumor xenografts leads to inhibition of tumor growth and tumor angiogenesis. SF/HGF is expressed and secreted mainly by tumor cells and acts on c-Met receptors that are expressed in tumor cells and vascular endothelial cells. Activation of c-Met leads to induction of proliferation, migration, and invasion and to inhibition of apoptosis in tumor cells as well as in tumor vascular endothelial cells. Activation of tumor endothelial c-Met also induces extracellular matrix degradation, tubule formation, and angiogenesis in vivo. SF/HGF induces brain tumor angiogenesis directly through only partly known mechanisms and indirectly by regulating other angiogenic pathways such as VEGF. Different approaches to inhibiting SF/HGF and c-Met have been recently developed. These include receptor antagonism with SF/HGF fragments such as NK4, SF/HGF, and c-Met expression inhibition with U1snRNA/ribozymes; competitive ligand binding with soluble Met receptors; neutralizing antibodies to SF/HGF; and small molecular tyrosine kinase inhibitors. Use of these inhibitors in experimental tumor models leads to inhibition of tumor growth and angiogenesis. In this review, we summarize current knowledge of how the SF/HGF:c-Met pathway contributes to brain tumor malignancy with a focus on glioma angiogenesis.
References
Abounader, R., Ranganathan, S., Lal, B., Fielding, K., Book, A., Dietz, H., Burger, P., and Laterra, J. (1999) Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J. Natl. Cancer Inst. 91, 1548-1556.
Abounader, R., Lal, B., Luddy, C., Koe, G., Davidson, B., Rosen, E.M., and Laterra, J. (2002) In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J. 16, 108-110.
Abounader, R., Reznik, T., Kuchner, E., Kwon, S., Saldanha, U., Dasgupta, N., Russel, J., Eberhart, C., and Laterra, J. (2004a) Characterization of the scatter factor/hepatocyte growth factor: c-Met pathway in human medulloblastoma malignancy. Am. Assoc. Cancer Res. Available at http://aacr04.agora.com/planner (abstract 4348).
Abounader, R., Montgomery, R., Dietz, H., and Laterra, J. (2004b) Design and expression of chimeric U1/ribozyme transgenes. Methods Mol. Biol. 252, 209-219.[Medline]
Alexandrakis, M.G., Passam, F.J., Ganotakis, E., Dafnis, E., Dambaki, C., Konsolas, J., Kyriakou, D.S., and Stathopoulos, E. (2004) Bone mar row microvascular density and angiogenic growth factors in multiple myeloma. Clin. Chem. Lab. Med. 42, 1122-1126.[CrossRef][ISI][Medline]
Arrieta, O., Garcia, E., Guevara, P., Garcia-Navarrete, R., Ondarza, R., Rembao, D., and Sotelo, J. (2002) Hepatocyte growth factor is associ ated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94, 3210-3218.[CrossRef][ISI][Medline]
Beilmann, M., Birk, G., and Lenter, M.C. (2004) Human primary co-culture angiogenesis assay reveals additive stimulation and different angio genic properties of VEGF and HGF. Cytokine 26, 178-185.[CrossRef][ISI][Medline]
Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G.F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925.[CrossRef][ISI][Medline]
Birchmeier, C., and Gherardi, E. (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404-410.[CrossRef][ISI][Medline]
Boccaccio, C., Ando, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., and Comoglio, P.M. (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391, 285-288.[CrossRef][Medline]
Bottaro, D.P., Rubin, J.S., Faletto, D.L., Chan, A.M., Kmiecik, T.E., Vande Woude, G.F., and Aaronson, S.A. (1991) Identification of the hepato cyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.
Bowers, D.C., Fan, S., Walter, K.A., Abounader, R., Williams, J.A., Rosen, E.M., and Laterra, J. (2000) Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phospha tidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res. 60, 4277-4283.
Brockmann, M.A., Ulbricht, U., Gruner, K., Fillbrandt, R., Westphal, M., and Lamszus, K. (2003a) Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 52, 1391-1399.[CrossRef][ISI][Medline]
Brockmann, M.A., Papadimitriou, A., Brandt, M., Fillbrandt, R., Westphal, M., and Lamszus, K. (2003b) Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4. Clin. Cancer Res. 9, 4578-4585.
Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and Comoglio, P.M. (1992) Hepatocyte growth factor is a potent angiogenic factor which stimu lates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E.J., Fisher, R.J., Wang, L.M., and Vande Woude, G.F. (2001) Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA 98, 7443-7448.
Christensen, J.G., Schreck, R., Burrows, J., Kuruganti, P., Chan, E., Le, P., Chen, J., Wang, X., Ruslim, L., Blake, R., Lipson, K.E., Ramphal, J., Do, S., Cui, J.J., Cherrington, J.M., and Mendel, D.B. (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phe notypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 63, 7345-7355.
Cooper, C.S., Park, M., Blair, D.G., Tainsky, M.A., Huebner, K., Croce, C.M., and Vande Woude, G.F. (1984) Molecular cloning of a new transform ing gene from a chemically transformed human cell line. Nature 311, 29-33.[CrossRef][Medline]
Ding, S., Merkulova-Rainon, T., Han, Z.C., and Tobelem, G. (2003) HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 101, 4816-4822.
Furlong, R.A., Takehara, T., Taylor, W.G., Nakamura, T., and Rubin, J.S. (1991) Comparison of biological and immunochemical properties indi cates that scatter factor and hepatocyte growth factor are indistin guishable. J. Cell Sci. 100 (Pt 1), 173-177.
Gerritsen, M.E., Tomlinson, J.E., Zlot, C., Ziman, M., and Hwang, S. (2003) Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothe lial growth factor in human endothelial cells. Br. J. Pharmacol. 140, 595-610.[CrossRef][ISI][Medline]
Gherardi, E., Youles, M.E., Miguel, R.N., Blundell, T.L., Iamele, L., Gough, J., Bandyopadhyay, A., Hartmann, G., and Butler, P.J. (2003) Functional map and domain structure of MET, the product of the c-met protoon cogene and receptor for hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 100, 12039-12044.
Grant, D.S., Kleinman, H.K., Goldberg, I.D., Bhargava, M.M., Nickoloff, B.J., Kinsella, J.L., Polverini, P., and Rosen, E.M. (1993) Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90, 1937-1941.
Grant, D.S., Rose, R.W., Kinsella, J.K., and Kibbey, M.C. (1995) Angiogenesis as a component of epithelial-mesenchymal interactions. EXS 74, 235-248.[Medline]
Hayashi, S., Morishita, R., Higaki, J., Aoki, M., Moriguchi, A., Kida, I., Yoshiki, S., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogihara, T. (1996) Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem. Biophys. Res. Commun. 220, 539-545.[CrossRef][ISI][Medline]
Hecht, M., Papoutsi, M., Tran, H.D., Wilting, J., and Schweigerer, L. (2004) Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res. 64, 6109-6118.
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C.P., Weirich, G., Kishida, T., Zbar, B., and Vande Woude, G.F. (1997) Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA 94, 11445-11450.
Jiang, W.G., Hiscox, S.E., Parr, C., Martin, T.A., Matsumoto, K., Nakamura, T., and Mansel, R.E. (1999) Antagonistic effect of NK4, a novel hepato cyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin. Cancer Res. 5, 3695-3703.
Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E., Hudson, E.A., Resau, J.H., and Vande Woude, G.F. (1997) Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57, 5391-5398.
Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., and Nakamura, T. (2000) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res. 60, 6737-6743.
Kuhnen, C., Muehlberger, T., Honsel, M., Tolnay, E., Steinau, H.U., and Muller, K.M. (2003) Impact of c-Met expression on angiogenesis in soft tissue sarcomas: Correlation to microvessel-density. J. Cancer Res. Clin. Oncol. 129, 415-422.[CrossRef][ISI][Medline]
Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., and Tahara, E. (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem. Biophys. Res. Commun. 189, 227-232.[CrossRef][ISI][Medline]
Kunkel, P., Müller, S., Schirmacher, P., Stavrou, D., Fillbrandt, R., Westphal, M., and Lamszus, K. (2001) Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro-Oncology 3, 82-88.[Abstract]
Lafleur, M.A., Handsley, M.M., Knauper, V., Murphy, G., and Edwards, D.R. (2002) Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115, 3427-3438.
Lal, B., Xia, S., Abounader, R., and Laterra, J. (2005) Targeting the c-Met pathway potentiates glioblastoma responses to 
-radiation. Clin. Cancer Res. 11, 4479-4486
Lamszus, K., Jin, L., Fuchs, A., Shi, E., Chowdhury, S., Yao, Y., Polverini, P.J., Laterra, J., Goldberg, I.D., and Rosen, E.M. (1997) Scatter factor stimu lates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab. Invest. 76, 339-353.[ISI][Medline]
Lamszus, K., Schmidt, N.O., Jin, L., Laterra, J., Zagzag, D., Way, D., Witte, M., Weinand, M., Goldberg, I.D., Westphal, M., and Rosen, E.M. (1998) Scatter factor promotes motility of human glioma and neuro microvascular endothelial cells. Int. J. Cancer 75, 19-28.[CrossRef][ISI][Medline]
Lamszus, K., Laterra, J., Westphal, M., and Rosen, E.M. (1999) Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int. J. Dev. Neurosci. 17, 517-530.[CrossRef][ISI][Medline]
Laterra, J., Nam, M., Rosen, E., Rao, J.S., Lamszus, K., Goldberg, I.D., and Johnston, P. (1997a) Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab. Invest. 76, 565-577.[ISI][Medline]
Laterra, J., Rosen, E., Nam, M., Ranganathan, S., Fielding, K., and John ston, P. (1997b) Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem. Biophys. Res. Commun. 235, 743-747.[CrossRef][ISI][Medline]
Ma, H., Calderon, T.M., Fallon, J.T., and Berman, J.W. (2002) Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 164, 79-87.[CrossRef][ISI][Medline]
MacDonald, T.J., Brown, K.M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R.J., Cogen, P., and Stephan, D.A. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29, 143-152.[CrossRef][ISI][Medline]
Madden, S.L., Cook, B.P., Nacht, M., Weber, W.D., Callahan, M.R., Jiang, Y., Dufault, M.R., Zhang, X., Zhang, W., Walter-Yohrling, J., Rouleau, C., Akmaev, V.R., Wang, C.J., Cao, X., St. Martin, T.B., Roberts, B.L., Teicher, B.A., Klinger, K.W., Stan, R.-V., Lucey, B., Carson-Walter, E.B., Laterra, J., and Walter, K.A. (2004) Vascular gene expression in non neoplastic and malignant brain. Am. J. Pathol. 165, 601-608.
Martin, T.A., Harding, K.G., and Jiang, W.G. (1999) Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis 3, 69-76.[CrossRef][Medline]
Martin, T.A., Mansel, R., and Jiang, W.G. (2001) Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endo thelial cells. Clin. Cancer Res. 7, 734-737.
Martinez-Rumayor, A., Arrieta, O., Guevara, P., Escobar, E., Rembao, D., Salina, C., and Sotelo, J. (2004) Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas. Cancer Lett. 213, 117-124.[CrossRef][ISI][Medline]
Matsumoto, K., and Nakamura, T. (2003) NK4 (HGF-antagonist/angiogene sis inhibitor) in cancer biology and therapeutics. Cancer Sci. 94, 321-327.[CrossRef][Medline]
Michalopoulos, G.K., and DeFrances, M.C. (1997) Liver regeneration. Science 276, 60-66.
Michieli, P., Mazzone, M., Basilico, C., Cavassa, S., Sottile, A., Naldini, L., and Comoglio, P.M. (2004) Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell 6, 61-73.[CrossRef][ISI][Medline]
Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y., and Kitamura, N. (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepa tocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 268, 10024-10028.
Moriyama, T., Kataoka, H., Kawano, Y., Yokogami, K., Nakano, S., Goya, T., Uchino, H., Koono, M., and Wakisaka, S. (1998a) Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett. 124, 149-155.[CrossRef][ISI][Medline]
Moriyama, T., Kataoka, H., Hamasuna, R., Yokogami, K., Uehara, H., Kawano, H., Goya, T., Tsubouchi, H., Koono, M., and Wakisaka, S. (1998b) Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human gli oma cells. Biochem. Biophys. Res. Commun. 249, 73-77.[CrossRef][ISI][Medline]
Muleris, M., Almeida, A., Dutrillaux, A.M., Pruchon, E., Vega, F., Delattre, J.-Y., Poisson, M., Malfoy, B., and Dutrillaux, B. (1994) Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9, 2717-2722.[ISI][Medline]
Nakagami, H., Morishita, R., Yamamoto, K., Taniyama, Y., Aoki, M., Mat sumoto, K., Nakamura, T., Kaneda, Y., Horiuchi, M., and Ogihara, T. (2001) Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 37, 581-586.
Nakamura, T., Nawa, K., and Ichihara, A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatecto mized rats. Biochem. Biophys. Res. Commun. 122, 1450-1459.[CrossRef][ISI][Medline]
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443.[CrossRef][Medline]
Nakamura, Y., Morishita, R., Higaki, J., Kida, I., Aoki, M., Moriguchi, A., Yamada, K., Hayashi, S.I., Yo, Y., Matsumoto, K., Nakamura, T., and Ogihara T. (1995) Expression of local hepatocyte growth factor system in vascular tissues. Biochem. Biophys. Res. Commun. 215, 483-488.[CrossRef][ISI][Medline]
Oh, I.S., So, S.S., Jahng, K.Y., and Kim, H.G. (2002) Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 296, 401-405.[CrossRef][ISI][Medline]
O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994) Angio statin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.[CrossRef][ISI][Medline]
Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayoyou, G., and Comoglio, P.M.(1994) A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261-271.[CrossRef][ISI][Medline]
Purdie, K.J., Whitley, G.S., Johnstone, A.P., and Cartwright, J.E. (2002) Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardio vasc. Res. 54, 659-668.
Reisinger, K., Kaufmann, R., and Gille, J. (2003) Increased Sp1 phosphory lation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J. Cell Sci. 116, 225-238.
Rosen, E.M., Lamszus, K., Laterra, J., and Poverini, P.J. (1999) Scatter factor as a tumor angiogenesis factor. In: Rubanyi, G.M. (Ed.), Angiogenesis in Health and Disease: Basic Mechanisms and Clinical Applications. New York: Marcel Dekker, Inc., pp. 145-156.
Rosen, E.M., Laterra, J., Joseph, A., Jin, L., Fuchs, A., Way, D., Witte, M., Weinand, M., and Goldberg, I.D. (1996) Scatter factor expression and regulation in human glial tumors. Intl. J. Cancer 67, 248-255.[CrossRef][ISI][Medline]
Rosen, E.M., Meromsky, L., Setter, E., Vinter, D.W., and Goldberg, I.D. (1990) Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10, 49-64.[ISI][Medline]
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699-702.[CrossRef][Medline]
Schmidt, L., Duh, F.M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S.W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U.R., Feltis, J.T., Casadevall, C., Zamarron, A., Ber nues, M., Richard, S., Lips, C.J.M., Walther, M.M., Tsui, L.-C., Geil, L., Orcutt, M.L., Stackhouse, T., Lipan, J., Slife, L., Brauch, H., Decker, J., Niehans, G., Hughson, M.D., Moch, H., Storkel, S., Lerman, M.I., Linehan, W.M., and Zbar, B. (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68-73 (letter).[CrossRef][ISI][Medline]
Schmidt, N.O., Westphal, M., Hagel, C., Ergun, S., Stavrou, D., Rosen, E.M., and Lamszus, K. (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int. J. Cancer 84, 10-18.[CrossRef][ISI][Medline]
Seki, T., Hagiya, M., Shimonishi, M., Nakamura, T., and Shimizu, S. (1991) Organization of the human hepatocyte growth factor-encoding gene. Gene 102, 213-219.[CrossRef][ISI][Medline]
Sengupta, S., Gherardi, E., Sellers, L.A., Wood, J.M., Sasisekharan, R., and Fan, T.P. (2003) Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 23, 69-75.
Skoldenberg, E.G., Christiansson, J., Sandstedt, B., Larsson, A., Lackgren, G., and Christofferson, R. (2001) Angiogenesis and angiogenic growth factors in Wilms tumor. J. Urol. 165, 2274-2279.[CrossRef][ISI][Medline]
Sonnenberg, E., Meyer, D., Weidner, K.M., and Birchmeier, C. (1993) Scat ter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123, 223-235.
St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Montgomery, E., Lal, A., Riggins, G.J., Lengauer, C., Vogelstein, B., and Kinzler, K.W. (2000) Genes expressed in human tumor endothelium. Science 289, 1197-1202.
Stoker, M., and Perryman, M. (1985) An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77, 209-223.[Abstract]
Tacchini, L., Matteucci, E., De Ponti, C., and Desiderio, M.A. (2003) Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. Exp. Cell Res. 290, 391-401.[CrossRef][ISI][Medline]
Tomita, N., Morishita, R., Taniyama, Y., Koike, H., Aoki, M., Shimizu, H., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogihara, T. (2003) Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107, 1411-1417.
Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kitamura, N. (1995) Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373, 702-705.[CrossRef][Medline]
Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., and Isner, J.M. (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation 97, 381-390.
Wagatsuma, S., Konno, R., Sato, S., and Yajima, A. (1998) Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82, 520-530.[CrossRef][ISI][Medline]
Walter, K.A., Hossain, M.A., Luddy, C., Goel, N., Reznick, T.E., and Laterra, J. (2002) Scatter factor/hepatocyte growth factor stimulation of glio blastoma cell cycle progression through G(1) is c-Myc dependent, and independent of p27 suppression, cdk2 activation, or E2F1-dependent transcription. Mol. Cell. Biol. 22, 2703-2715.
Wang, H., and Keiser, J.A. (2000) Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem. Biophys. Res. Commun. 272, 900-905.[CrossRef][ISI][Medline]
Wang, X., Zhou, Y., Kim, H.P., Song, R., Zarnegar, R., Ryter, S.W., and Choi, A.M. (2004) Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J. Biol. Chem. 279, 5237-5243.
Weidner, K.M., Arakaki, N., Hartmann, G., Vandekereckhove, J., Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., and Daikuhara, Y. (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 88, 7001-7005.
Wojta, J., Kaun, C., Breuss, J.M., Koshelnick, Y., Beckmann, R., Hattey, E., Mildner, M., Weninger, W., Nakamura, T., Tschachler, E., and Binder, B.R. (1999) Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor fl k-1 in human endothelial cells. Lab. Invest. 79, 427-438.[ISI][Medline]
Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N., and Gerritsen, M.E. (2001) Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 158, 1111-1120.
Yamamoto, K., Morishita, R., Hayashi, S., Matsushita, H., Nakagami, H., Moriguchi, A., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogi hara, T. (2001) Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells. Hypertension 37, 1341-1348.
Zhang, Y.-W., Su, Y., Volpert, O.V., and Vande Woude, G.F. (2003) Hepa tocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100, 12718-12723.
This article has been cited by other articles:
|
|
 |
|
  P. N. Kongkham, P. A. Northcott, Y. S. Ra, Y. Nakahara, T. G. Mainprize, S. E. Croul, C. A. Smith, M. D. Taylor, and J. T. Rutka An Epigenetic Genome-Wide Screen Identifies SPINT2 as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma Cancer Res., December 1, 2008; 68(23): 9945 - 9953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Trapp, G. Kogler, A. El-Khattouti, R. V. Sorg, M. Besselmann, M. Focking, C. P. Buhrle, I. Trompeter, J. C. Fischer, and P. Wernet Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury J. Biol. Chem., November 21, 2008; 283(47): 32244 - 32253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Binning, T. Niazi, C. A. Pedone, B. Lal, C. G. Eberhart, K. J. Kim, J. Laterra, and D. W. Fults Hepatocyte Growth Factor and Sonic Hedgehog Expression in Cerebellar Neural Progenitor Cells Costimulate Medulloblastoma Initiation and Growth Cancer Res., October 1, 2008; 68(19): 7838 - 7845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kendall, J. Najbauer, H. F. Johnston, M. Z. Metz, S. Li, M. Bowers, E. Garcia, S. U. Kim, M. E. Barish, K. S. Aboody, et al. Neural Stem Cell Targeting of Glioma Is Dependent on Phosphoinositide 3-Kinase Signaling Stem Cells, June 1, 2008; 26(6): 1575 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Reznik, Y. Sang, Y. Ma, R. Abounader, E. M. Rosen, S. Xia, and J. Laterra Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor Mol. Cancer Res., January 1, 2008; 6(1): 139 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Hoelzinger, T. Demuth, and M. E. Berens Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment J Natl Cancer Inst, November 7, 2007; 99(21): 1583 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Matteucci, E. Ridolfi, P. Maroni, P. Bendinelli, and M. A. Desiderio c-Src/Histone Deacetylase 3 Interaction Is Crucial for Hepatocyte Growth Factor Dependent Decrease of CXCR4 Expression in Highly Invasive Breast Tumor Cells Mol. Cancer Res., August 1, 2007; 5(8): 833 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Martens, N.-O. Schmidt, C. Eckerich, R. Fillbrandt, M. Merchant, R. Schwall, M. Westphal, and K. Lamszus A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo. Clin. Cancer Res., October 15, 2006; 12(20): 6144 - 6152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax Pericellular Proteases in Angiogenesis and Vasculogenesis Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 716 - 728. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
